First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort.
APA
Ma X, Ou K, et al. (2026). First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort.. Discover oncology. https://doi.org/10.1007/s12672-026-04853-0
MLA
Ma X, et al.. "First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort.." Discover oncology, 2026.
PMID
41863740
같은 제1저자의 인용 많은 논문 (5)
- The tumor microenvironment as a key regulator of radiotherapy response.
- Genetic disruption of mitochondrial dynamics and stasis leads to liver injury and tumorigenesis.
- Mitochondrial dynamics, quality control, and mtDNA in alcohol-associated liver disease and liver cancer.
- ALKBH5 facilitates acute myeloid leukemia development and immune escape via PD-L1 regulation.
- Immunohistochemical detection of PD-L1 in small cell lung cancer and its prognostic values.